CMLF CM Life Sciences, Inc. - Class A

Blank check.

On 2/10/2021 the company announced a pending merger with Mount Sinai Genomics, Inc. d/b/a Sema4 an AI-driven patient-centered genomic and clinical data insight platform company founded on the idea that more information, deeper analysis, and increased engagement will improve the diagnosis, treatment, and prevention of disease.  

$11.60  -0.88 (-7.05%)
As of 07/22/2021 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Financials
Industry:  Shell Companies
Index country:  USA
Country of incorporation:  
IPO date:  10/26/2020
Outstanding shares:  44,275,000
Average volume:  672,207
Market cap:   $513,590,000
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    18978W109
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   128.89
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy